NCT00617981Phase 3Completed

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

Study sponsor: Imunon

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2013-01Actual
Enrollment · participants701Actual
Source updated2024-05-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.